The latest news on MS treatments, research and specialist services.
MS Trust news
News from the MS Trust
Views and comment
MS Trust staff, MS health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
Maureen has supported the MS Trust for many years, having lived with MS for over 40 years herself. Last autumn, she decided to do a skydive – aged 72 – to fundraise for the MS Trust and she has also left a legacy gift to us in her will
For 20 years the MS Trust has provided free, evidence-based information for anyone affected by MS – via our enquiry service, our printed publications, and, increasingly, our online and social media resources. We hope to help people understand more about their condition, consider their options and work effectively with their MS teams. Here we introduce some of the members of our award-winning team and some of the people they’ve helped
The MS Trust and University Hospitals of Leicester NHS Trust are working together to make a difference for local people living with MS with the recruitment of the first new nurse placements in the MS Trust’s Specialist Nurse Funding Programme. We went to Leicester to speak to Allison, one of the existing MS nurses, and Jon, who has been living with MS for almost ten years, about the difference the new nurses will make.
Have the feats of Paralympic champions Kadeena Cox and Stephanie Millward inspired you to lace up those trainers and get fit? Specialist neuro-physiotherapist Liz Betts, who helped develop the exercises on our website, offers some advice on staying fit when you have MS, and we hear from two people with MS who have benefitted from a more active lifestyle
After an MS diagnosis you’re bound to have worries about how the condition might impact your independence and freedom: will you still be able to do those ‘normal’ everyday things you always have done? One of the most common questions that our information team gets asked is: ‘Can I still drive?’ For most people with MS the answer is ‘Yes’, but there are some things you need to be aware of.
Thank you and congratulations to the MS Trust London Marathon team who have raised over £115,000 to help people with MS.
Emergency hospital admissions for people with MS are on the rise, according to new research published today by the MS Trust and Wilmington Healthcare. These cause distress for people with MS and cost the NHS millions, yet many of them could be avoided.
MS Trust names first sites in specialist nurse funding programme and announces plans to fund a further six new posts in the next year
- Genes and MS risk
- Tecfidera and NEDA
- Early warnings of future MS diagnosis revealed in medical history
We wish the best of luck to our 54 runners for the London Marathon on Sunday and share details of our cheering points.
- Eating and MS
- Life expectancy measured
- Vehicle leasing affected by benefit changes
- Lemtrada and listeria
Iona Creedon, who was diagnosed with MS 10 years ago, has started a new blog all about gardening and MS called Gardening within liMitS. Here she talks about the inspiration behind it, reveals plans for her own garden, and shares some green-fingered wisdom.
The Scottish Medicines Consortium (SMC) has approved Zinbryta (daclizumab) as a treatment for relapsing remitting multiple sclerosis on the NHS in Scotland.
Today the MS Trust is launching its Put MS on the Map campaign, helping raise awareness of the vital role MS nurses play in supporting people with MS to live life to the full.
Join Bradford MS specialist nurse Liz Watson and take to the skies at our Big Blue Jump in Lancashire to support people living with MS.
Charlotte from Hampshire explains how a clear out at home kick-started a car boot sale campaign to help others who have MS.
- Ocrelizumab approved in US for relapsing and progressive MS
- Kidney and bladder stone risk
- ADHD in children of women with MS
Ocrelizumab (Ocrevus) has become the first medicine to be licensed for primary progressive MS by the FDA (Food and Drug Administration), the American drug regulators. The FDA has also licensed ocrelizumab as a treatment for relapsing remitting MS.
- Anxiety and the link to depression
- Anxiety and psychosocial factors
- Invisible disability toilet signs
- Trigeminal neuralgia at onset of MS